Transaction overview
Clark-Reliance (US), a provider of liquid level instrumentation and controls, acquired John C. Ernst & Co., Inc. (US) on July 27, 2023. The deal size was undisclosed, but it is known that Clark-Reliance purchased the entire stake in John C. Ernst. John C. Ernst specializes in engineered measurement solutions and process observation equipment for liquid and steam applications, with a broad range of products including sight flow indicators, liquid level gauges, and flow meter products.
Deal structure and financing
The financial details of the acquisition were not disclosed. The transaction involved Wiley Brothers - Aintree Capital as the sell-side advisor to John C. Ernst and the Wolfe brothers. Specific terms such as equity split, debt involvement, leverage metrics, or any lock-up periods for the seller’s retained stake are unavailable. Given that the deal rationale emphasizes strategic rather than financial motivations, it is likely structured as an all-cash transaction with no equity component from John C. Ernst shareholders.
Strategic context
Clark-Reliance's acquisition of John C. Ernst was driven by the desire to enhance its portfolio of engineered measurement and process observation equipment products and solutions. The addition of John C. Ernst’s application expertise and customer reach complements Clark-Reliance’s existing industry-leading brands such as Jerguson, Jacoby-Tarbox, and Ernst Flow Industries. For John C. Ernst, joining a larger entity like Clark-Reliance provides the opportunity to leverage its market position further with enhanced capabilities and broader distribution networks.
Regulatory path
The regulatory review process for this acquisition is not disclosed publicly. Given the nature of the industries involved—manufacture and distribution of specialized industrial equipment—the deal likely underwent scrutiny by antitrust authorities in relevant jurisdictions such as the United States Federal Trade Commission (FTC) or Department of Justice (DOJ). No specific details on remedies, timelines, or filing dates are available. The transaction's undisclosed status suggests a relatively straightforward regulatory path without significant hurdles from competition regulators.